Kenneth heston Bardales
๐Ÿ“ฃ ๐— ๐—ผ๐—ป๐˜๐—ต๐—น๐˜† ๐—ฃ๐—ผ๐—ฟ๐˜๐—ณ๐—ผ๐—น๐—ถ๐—ผ ๐—จ๐—ฝ๐—ฑ๐—ฎ๐˜๐—ฒ โ€“ ๐—ก๐—ผ๐˜ƒ๐—ฒ๐—บ๐—ฏ๐—ฒ๐—ฟ ๐Ÿฎ๐Ÿฌ๐Ÿฎ๐Ÿฑ ๐ŸŒฑ โ€ข ๐— ๐—ผ๐—ป๐˜๐—ต๐—น๐˜† ๐—ฅ๐—ฒ๐˜๐˜‚๐—ฟ๐—ป: -5.27% โ€ข ๐—ฌ๐—ง๐——: +21.40% ๐—ง๐—ผ๐—ฝ ๐—–๐—ผ๐—ป๐˜๐—ฟ๐—ถ๐—ฏ๐˜‚๐˜๐—ผ๐—ฟ๐˜€ (๐— ๐—ง๐——): โ€ข Merck & Co. (MRK): +27.85% โ€ข Barrick Mining Corp (B): +21.06% โ€ข VanEck Vectors Gold Miners ETF (GDX): +13.55% ๐—•๐—ถ๐—ด๐—ด๐—ฒ๐˜€๐˜ ๐——๐—ฒ๐˜๐—ฟ๐—ฎ๐—ฐ๐˜๐—ผ๐—ฟ๐˜€ (๐— ๐—ง๐——): โ€ข Strategy Inc (MSTR): -33.84% โ€ข Cardano (ADA): -30.32% โ€ข ZEPP Health Corp.-ADR (ZEPP): -25.86% ๐—–๐—ผ๐—บ๐—บ๐—ฒ๐—ป๐˜๐—ฎ๐—ฟ๐˜† This month the portfolio recorded a negative return while the year to date performance remains robust. Strong contributions from healthcare and mining helped cushion the portfolio during a challenging period for selective growth and digital assets. Merck outperformed on solid fundamentals and favorable sector dynamics, while Barrick and the gold miners benefited from commodity strength and risk hedging flows. Losses were concentrated in a few high volatility positions which amplified downside in the month. Our disciplined sizing and hedging framework limited drawdowns and preserved optionality. Going forward we will monitor earnings revisions, commodity trends and interest rate signals to adjust exposures where probabilities of asymmetric reward improve. The focus remains on quality names with durable cash generation and margin resilience while remaining ready to capture opportunities created by short term dislocations. ๐—•๐—ฒ๐—ป๐—ฐ๐—ต๐—บ๐—ฎ๐—ฟ๐—ธ ๐—–๐—ผ๐—ป๐˜๐—ฒ๐˜…๐˜ โ€” VOO (S&P 500): +16.23% YTD | QQQ (NASDAQ 100): +20.36% YTD ๐Ÿ“„ Fact sheet: bullaware.com/etoro/khbardales ๐Ÿ’ก This portfolio is structured for long term growth with a multi year horizon. Thank you for your continued trust and support.
null
.